Ian Hudson takes over as new chief of UK's drugs regulator
The UK's drugs regulator on Monday announced that Dr Ian Hudson has taken over as its new chief executive.
Hudson replaces the Medicines and Healthcare Products Regulatory Agency's (MHRA) former chief executive, professor Sir Kent Woods, who has stepped down after 10 years with the organisation, according to a statement.
Woods had been chief executive of the agency since 2004, following a role as director of the National Health Service Health Technology Assessment Programme.
Hudson was previously the MHRA's director of licensing for 12 years, responsible for the majority of medicines licensing activities in the UK.
The move was originally announced in July, although, when contacted by APM, the MHRA could not immediately say who will replace Hudson as the MHRA's representative on Europe's CHMP scientific committee.